Elastin is an abundant extracellular matrix protein in elastic tissues, including the lungs, skin and arteries, and comprises 30-57% of the aorta by dry mass. The monomeric precursor, tropoelastin (TE), undergoes complex processing during elastogenesis to form mature elastic fibres. Peroxynitrous acid (ONOOH), a potent oxidising and nitrating agent, is formed in vivo from superoxide and nitric oxide radicals. Considerable evidence supports ONOOH formation in the inflamed artery wall, and a role for this species in the development of human atherosclerotic lesions, with ONOOH-damaged extracellular matrix implicated in lesion rupture. We demonstrate that TE is highly sensitive to ONOOH, with this resulting in extensive dimerization, fragmentation and nitration of Tyr residues to give 3-nitrotyrosine (3-nitroTyr). This occurs with equimolar or greater levels of oxidant and increases in a dose-dependent manner. Quantification of Tyr loss and 3-nitroTyr formation indicates extensive Tyr modification with up to two modified Tyr per protein molecule, and up to 8% conversion of initial ONOOH to 3-nitroTyr. These effects were modulated by bicarbonate, an alternative target for ONOOH. Interand intra-protein di-tyrosine cross-links have been characterized by mass spectrometry. Examination of human atherosclerotic lesions shows colocalization of 3-nitroTyr with elastin epitopes, consistent with TE or elastin modification in vivo, and also an association of 3-nitroTyr containing proteins and elastin with lipid deposits. These data suggest that exposure of TE to ONOOH gives marked chemical and structural changes to TE and altered matrix assembly, and that such damage accumulates in human arterial tissue during the development of atherosclerosis.
Introduction
Elastic fibres are large extracellular matrix (ECM) macromolecules composed of microfibrils and elastin. These structures are highly abundant and responsible for the resilience and recoil capabilities of tissue and organs [1] , with elastin constituting 30-57% of the aorta and 28-32% of major vascular vessels by dry mass [2] [3] [4] . Elastin is predominantly expressed during embryogenesis and tissue development and has a low turnover rate in healthy tissues. However, if elastic fibres are subject to injury, tissue repair mechanisms are initiated and synthesis of new elastin can be rapidly activated [5] .
Impaired elastogenesis contributes to a number of human pathologies (e.g. supravalvular aortic stenosis [6] , cutis laxa [7] , Hurler disease [8] , and Costello syndrome [9] ). Disruption of the elastin gene, by targeted inactivation, indicates that elastin plays an essential role in arterial morphogenesis [10, 11] . Homozygous elastin-deficient mice die of obstructive arterial disease after birth [10] , whereas heterozygote mice with one allele for elastin show increased elastic lamellae in their arteries [11] . It is known that arterial development is associated with an increase in the number of elastic lamellae [11] . These changes are perturbed during the development of atherosclerotic plaques [12] , as a result of flow-induced dilatation [13] , and non-atherosclerotic intimal thickening [14, 15] . A number of stimuli linked with atherosclerosis can evoke elastogenesis [16, 17] , with duplication of elastic lamellae detected in healed arteritis and some atheroma. The structure and integrity of elastin within the artery wall is known to change with age [18, 19] and it has been reported that elastin fragments can stimulate the development of atherosclerosis through modulation of immune signalling pathways (Neu1-PI3K-gamma) [20] .
The precursor protein of mature elastin, tropoelastin (TE), is encoded by a single gene, with 11 different isoforms reported to date [21] . Elastogenic cells such as smooth muscle cells, fibroblasts and macrophages, express and release monomeric TE in the extracellular space where it forms clusters bound to integrins and glycosaminoglycans on the cell surface [22, 23] . Elastogenesis, the secretion, coacervation and deposition of TE onto elastic fibres, and crosslinking of elastin monomers is a multistep process involving interaction with other matrix proteins including fibrillin-1, fibulins-4 and -5 and perlecan [24] [25] [26] . Coacervation, the self-assembly of monomeric TE to spherical globules, is an entropically-driven reversible process [4] . Increasing temperature supresses clathrate-like associated water from hydrophobic domains and allows these domains to align and aggregate [21, 27] . TE-spherols are deposited onto a scaffold of microfibrils and are cross-linked [28, 29] . Lysine residues are oxidised by the enzyme lysyl oxidase to form allysine, with spontaneous condensation of two allysine molecules, or an allysine, with another Lys residues giving rise to irreversible crosslinks and elastic fibre growth [21, 30] .
It has been shown that there are significant changes in elastin content within the artery wall during the development of cardiovascular disease and particularly atherosclerosis [31, 32] . Elastic fibre content within the plaque area has been reported to increase with this associated with increased lipid deposition and binding of calcium ions, with up to 40% of the total calcium content of lesions reported to be bound to elastin [33] . In contrast, elastin levels within the fibrous cap of lesions appears to decrease during lesion development, and this is believed to play a role in the weakening of this structure making it more prone to rupture [34] , a major cause of heart attacks and strokes [35, 36] .
Macrophages are known to accumulate at sites of inflammation, including within the artery wall, with these cells reported to play a key role in ECM remodelling via altered excretion and activation of matrix metalloproteinases (MMPs) and their inhibitors (tissue inhibitors of metalloproteinases, TIMPs) [37] , with the finely-tuned balance between these activities appearing to be altered during the development and progression of atherosclerosis [38, 39] . Activated macrophages are also known to release a battery of reactive oxidants via the activities of NADPH oxidases (which generate superoxide radicals, O 2 -.
, and hydrogen peroxide, H 2 O 2 ) and inducible nitric oxide synthase, which generate nitric oxide, NO
. [40] . The rapid (diffusion-controlled) reaction of O 2 -. with NO . yields the powerful oxidant peroxynitrous acid (ONOOH), which exists at physiological pH values in equilibrium with its less-reactive anion form, peroxynitrite (ONOO -, pKa 6.7) [41, 42] . ONOOH can undergo both direct (2-electron) oxidation reactions, as well as undergo limited homolysis to give hydroxyl radicals (HO .
) and nitrogen dioxide (NO 2 . ) radicals [43, 44] . In the presence of physiological concentrations of CO 2 (which is in equilibrium with~25 mM HCO 3 -), the adduct species peroxynitrosocarbonate, ONOOCO 2 -, is formed that can also induce direct oxidations and give rise to the radicals CO 3 -. and NO 2 . as a result of homolysis [43] . Both ONOOH and ONOOCO 2 -can give rise to nitrated products from biological targets, with these including 3-nitrotyrosine (3-nitroTyr), a product of proteinbound tyrosine, and 6-nitrotryptophan, a product of protein-bound tryptophan [43, 45] . These stable products are believed to arise via the initial formation of Tyr-derived phenoxyl radicals, and Trp-derived indolyl radicals, and subsequent reaction with NO 2 . to give nitrated products. 3-NitroTyr has been reported to be present at elevated levels in all grades of human atherosclerotic lesions and present on multiple proteins [46] , including high-and low-density-lipoproteins [47] , and the ECM materials perlecan [48] , laminin [49] and fibronectin [50] . Furthermore, immunoglobulins against 3-nitroTyr epitopes have been detected in human atherosclerotic lesions and the circulation of subjects with coronary artery disease, linking oxidant production and activation of the immune system [51] . The role of oxidants in modifying ECM and its consequences has been reviewed [52] [53] [54] . ECM modification by ONOOH can result in changes in cell function, including altered cell adhesion and proliferation and changes in gene regulation and cytokine expression [54] . Elastin isolated from plaques has been reported to have an altered amino acid composition and this is thought to be a prerequisite for the binding of cholesterol esters (from low-density lipoproteins) within plaques, a process that does not appear to occur to a significant extent with normal elastin [34, 55] . Vascular remodelling, a major feature of atherosclerotic plaque development, has also been reported to be characterized by elastin fragmentation, a decrease in overall elastin content, and an increase in both collagen content and collagen crosslinking. These processes have been associated with increased arterial stiffness and calcification [19, 31, [56] [57] [58] .
As elastin is present in many tissues in close proximity to other ECM proteins that are oxidised by ONOOH (e.g. perlecan [26, 48] ), we hypothesized that elastin would also be a likely target, and due to its high abundance in major vessels might consume a major portion of ONOOH or ONOOCO 2 -generated in vivo. Previous studies using very high levels of ONOOH support this assertion [59, 60] . Furthermore due to its unusual amino acid composition (TE contains no Met, Trp, His or free Cys residues, which are all favoured targets of ONOOH [61, 62] ), and a relatively high content of Tyr residues (15), it might be expected that this protein would give rise to particularly high yields of 3-nitroTyr. Such modifications might affect both the structure and biological activity of this protein. As previous studies have suggested that exposure of cells to modified ECM can alter gene expression [63] and promote inflammation [64] , the presence of elastin modifications has also been examined in vivo in human atherosclerotic lesions.
Materials and methods

Materials
Recombinant full-length TE was expressed and purified from an E. coli expression system as described previously [65] . All other chemicals were from Sigma-Aldrich unless stated otherwise. Milli-Q grade water (Millipore Advantage A10; Merck-Millipore, Billerica, MA, USA) was used to prepare buffers, and all reaction mixtures were treated with Chelex-100 resin (Bio-Rad, Hercules, CA, USA) to remove trace metal ions. ONOOH was synthesised using a two-phase system from isoamyl nitrite and H 2 O 2 , as described previously [66] , with residual H 2 O 2 removed by treatment with MnO 2 . Stock solutions of the ONOOH were stored at − 80°C until use, and used immediately after thawing, with unused material discarded. The concentration of ONOOH solutions was determined spectrophotometrically at 302 nm using an extinction coefficient of 1705 M −1 cm −1 [67] . Decomposed oxidant solutions (indicated as dONOOH) were used as controls for any residual materials from the synthesis, with these being prepared by overnight incubation at 37°C in 0.1 M phosphate buffer, pH 7.4. Stock solutions of ONOOH were prepared in freshly prepared 0.1 M NaOH just before use in experiments, with low volumes of the oxidant added to strongly buffered solutions (100 mM phosphate buffer, pH 7.4) to prevent significant changes in pH. Reaction mixtures were prepared by rapidly adding ONOOH to centrifuge tubes with vortexing to ensure rapid homogenous reaction.
SDS-PAGE and Western blotting
TE was diluted in 100 mM phosphate buffer, pH 7.4, and exposed to ONOOH in either the absence or presence of NaHCO 3 (25 mM final concentration, to give physiological levels of CO 2 ), for 20 min at 21°C. With this incubation time complete consumption of ONOOH occurs [68] . Samples for analysis were prepared using NuPAGE ® LDS Sample For Coomassie staining, the gels were fixed and stained using 0.1% (w/v) Coomassie R-250 in 40% (v/v) ethanol and 10% (v/v) acetic acid and microwaved for 1 min on high power followed by 15 min incubation at 21°C on an orbital shaker. The staining solution was then removed and the gels were destained using 10% (v/v) ethanol and 7.5% (v/v) acetic acid in water with microwave exposure for 1 min. Gels were then incubated on an orbital shaker until a colorless background was achieved, and scanned using a standard flat bed scanner [49, 50] .
For silver staining, the gels were fixed in a solution containing 50% (v/v) methanol and 10% (v/v) acetic acid for 30 min, then incubated in 5% (v/v) methanol for 15 min and 3 times for 5 min in H 2 O to rehydrate the gels. The gels were then incubated in freshly prepared 0.02% (w/v) sodium thiosulfate for 2 min, washed for 2 min with H 2 O and stained with 0.2% (w/v) silver nitrate for 25 min. Unbound silver nitrate was removed by washing for 5 min with H 2 O. Gels were developed in a solution containing 3% (w/v) sodium carbonate, 0.0004% (w/v) sodium thiosulfate and 0.05% (v/v) formaldehyde until the desired staining intensity was achieved, with development terminated by treatment with 1.4% (w/v) EDTA [49, 50] .
For Western blotting experiments, proteins were electroblotted onto nitrocellulose membranes using an iBlot® transfer apparatus . In order to reduce background, unbound HRP was removed by extensive washing, 4 times for 10 min with PBST and twice with water for 10 min followed by detection of immune complexes with Western Lightning Plus ECL reagent (Perkin Elmer). Chemiluminescent images were acquired using an Image Quant LAS 4000 system (GE Healthcare), reference protein markers were visualized in normal brightfield and aligned to chemiluminescent images.
High performance/Ultra high performance liquid chromatography (HPLC/UHPLC)
Loss of parent amino acids and formation of 3-nitroTyr was quantified using two different UHPLC/HPLC methods. For analysis of total amino acids (method (a)) control and modified protein was carried out using acid hydrolysis with methanesulfonic acid as described previously [69] , using commercially available amino acid mixtures to generate standard curves and pre-column derivatization with the fluorescent tag o-phthaldialdehyde. The tagged amino acids were separated on a Shimadzu Nexera UHPLC system and eluted by gradient elution with buffer A consisting of 100 mM sodium acetate, pH 5.3, in water with 2.5% (v/v) tetrahydrofuran and 20% (v/v) methanol, and buffer B (100 mM sodium acetate, pH 5.3, in water with 2.5% (v/v) tetrahydrofuran and 80% (v/v) methanol). The gradient protocol consisted of an increase from 100% buffer A to 25% buffer B over 6 min, elution with this mixture for 1 min, then a gradient to 62% buffer B over 0.5 min, elution with 62% buffer B for 2.5 min, then a gradient to 100% buffer B over 2 min, elution with 100% buffer B for 1 min, then a gradient to 100% buffer A over 0.5 min, and re-equilibration with buffer A for a further 3.5 min. The tagged amino acids were detected with a Shimadzu, RF-20A fluorescence detector with λ Ex = 340 nm and λ Em = 440 nm.
3-NitroTyr generation on oxidant-treated and control protein (prepared as described above) was examined (method (b)) using samples containing 100 μg protein in 130 µL 0.1 M PBS. These were incubated with 20 µL of pronase solution (1 mg mL
; protein/enzyme ratio 5:1) and incubated for 24 h at 50°C in an incubator to release free amino acids. Undigested peptides and remaining enzyme were removed by filtration (Nanosep® 3 kDa cut off centrifugal filtration devices, 13,300 g, 30 min). Control samples containing only pronase were also prepared to determine the contribution of pronase auto-digestion to the free amino acid pool; these values are reported, but not subtracted, as they may over-estimate the extent of auto-digestion in the presence of substrate. Standard stock solutions of parent Tyr and 3-nitroTyr (either 100 μM or 1 mM) were also prepared then diluted as required. The filtrates from protein digestion were injected onto a Kromasil C18, 5 µm, 250×4.6 mm column together with a Pelliguard LC 18 guard column, and components separated using a gradient elution system on a Shimadzu HPLC system (SIL-20AC HT, LC-10AT, CTO-10AS; Shimdazu, Kyoto, Japan) equipped with a UV-VIS detector (SPD-10A) connected in series with a multi-channel Coularray electrochemical detector (5020 guard cell, 6210 Hi-E four sensor assembly; ESA, Chelmsford, MA, USA) with the column maintained at 30°C with a flow rate of 1 mL min
The elution gradient consisted of 100% buffer A (50 mM citric acid in water, pH 2.3, with 2% [v/v] acetonitrile) for 3 min, then a gradient to 70% buffer B (50 mM citric acid in water, pH 2.3, with 20% [v/v] acetonitrile) over 17 min, a gradient to 100% buffer B over 5 min, 100% buffer B for 10 min, then re-equilibration to 100% buffer A over 10 min. Detection and quantification of tyrosines (o-Tyr, m-Tyr, p-Tyr) was carried out using their UV absorption at 280 nm. These compounds were also detected electrochemically using the 12-channel Coularray electrochemical detector, but only 3-nitroTyr was quantified using this method. Electrode potentials were adjusted (50, 150, 250, 300, 350, 450, 500, 550, 620, 700, 810, 840 mV respectively) to achieve stepwise oxidation of compounds, with the integrations carried out on the peak intensities for three channels (dominant channel, and the channels before and after this) summed. Under these condition 3-nitroTyr was detected solely in channels 10-12, with a retention time of~30 min.
Mass spectrometric detection of protein cross-links
Twenty µg of TE (control or exposed to ONOOH as described above) was dissolved in 20 µL 8 M urea, 50 mM Tris-HCl at pH 8.0. Two microliters of dithiothreitol (DTT, 450 mM) was then added and incubated for 45 min at 21°C. Alkylation was carried out by adding iodoacetamide (IAM, 4 µL, 500 mM), followed by incubation for 60 min at 21°C in the dark. The sample was then divided into two fractions, for trypsin digestion in 16 O-and 18 O-water, respectively, followed by solid-phase extraction on activated StageTip C18 reversed-phase discs as reported elsewhere [70] . The immediately prior to analysis [70] . Mass spectrometric analysis of peptide samples was carried out on an EASY nLC 1000 chromatograph (Thermo Fischer Scientific) with an EASY-spray column (Pepmap Thermo Fischer Scientific; 3 µm, C18
15 cm × 75 µm) coupled online to an Orbitrap Fusion mass spectrometer (Thermo Fischer Scientific). Separation was performed with a flow rate of 250 nL min -1 and gradient of solvents A (0.1% trifluoroacetic acid, TFA) and B (80% acetonitrile and 0.1% TFA) and data acquisition was performed as previously described [70] , with high-energy collisional dissociation fragmentation (28% collision energy and 120,000 resolution, Orbitrap detection). MassAI (version April 2017, University of Southern Denmark) was used for identification and verification of cross-linked peptides in MS/MS spectra with the following settings: fixed (cysteine carbamidomethylation) and variable (methionine oxidation, tyrosine oxidation and nitration) modifications; maximum number of missed cleavages 2; parent mass tolerance 10 ppm; MS2 peak tolerance 0.02 m/z. The search criteria included intra-protein and xlink modified peptides. Positive candidates were re-evaluated manually by score and spectral analysis to ensure the presence of 4 Da mass shifts in the precursors. Quantification of the selected cross-linked peptides was performed manually based on the ion intensities originating from the corresponding peptide spectrum matches in three experimental replicates.
Immunohistochemical staining of human atherosclerotic lesions
Arteriae femuralis and aortae abdominalis samples were obtained within 12 h from 3 subjects who died of cerebral haemorrhage. Lesion severity was classified according to Stary and coworkers [71] and ranged here from microscopically normal to thickened intima (type II-III). Samples were immediately frozen in a cryostat (Microm HM500 OM; Microm, Walldorf, Germany), supported by tissue freezing medium (Tissue Tec OCT-compound; Miles, Elkhard, Ind., USA) [72] . Five μm serial cryosections were collected on glass slides, air-dried (2 h, 21°C), fixed in acetone (5 min, 21°C) and stored at −70°C until analysis. Approval of the institutional ethics committee was obtained for this study (Medical University Graz, EK-number: 29-464 ex 16/17). All methods were performed in accordance with the relevant guidelines and regulations.
For immunohistochemistry and double immunofluorescence, sections were thawed, fixed in acetone (21°C, 5 min), then rehydrated in PBS followed by blocking using Ultra V block for 10 min (Lab Vision, Fremont, CA, USA). For immunohistochemistry, sections were incubated (21°C, 30 min) with either mouse anti-elastin mAb (clone 10B8, Abcam, 1:100 dilution) or with rabbit anti-3-nitroTyr pAb (IgG; Merck-Millipore, 1:100 dilution). Detection of the signal was performed with the UltraVision system from LabVision, based on a peroxidaselabelled biotin-streptavidin system. Control experiments were performed by omission of the primary Ab or by preincubation of rabbit anti-3-nitroTyr pAb with a 12.5 -25 fold molar excess of nitrated TE or native TE. The competitor was preincubated with the primary antibody for 60 min before adding to the section. The slides were developed with aminoethylcarbazole (LabVision) (21°C, 4 min), counterstained with Mayer's hemalum and mounted with Kaiser's glycerolgelatine (Merck). Oil red stain of serial sections was performed as described [72] . Pictures were taken with a Leica CM 6000B microscope equipped with an Olympus DP72 camera. For double immunofluorescence, sections were incubated with mouse anti-elastin mAb (clone 10B8, Abcam, 1:100 dilution) followed by goat anti-mouse cyanine-2 (Cy-2)-labelled pAb (Jackson Dianova, 1:300 dilution). Afterwards slides were incubated with rabbit anti-3-nitroTyr pAb (Merck-Millipore, 1:100 dilution) followed by goat anti-rabbit Cy-3-labelled pAb (1:300 dilution) [73] . Sections were mounted with Moviol (Calbiochem-Novabiochem, La Jolla, USA) and analyzed using a confocal laser-scanning microscope operating in sequential mode (Leica SP2; Leica Lasertechnik GmbH, Heidelberg, Germany), with the 488 nm laser line used for Cy-2 excitation, and the 543 nm line for Cy-3. Emission detection used 500-540 nm (green staining) for Cy-2, and 560-620 nm (red staining) for Cy-3. Controls were performed by omitting the primary antibodies or by replacing them with non-immune rabbit IgG (Sigma-Aldrich) or non-immune mouse IgG (Sigma-Aldrich). PBS was used for all washing steps between the incubations and Dako antibody diluent for antibody dilutions. All incubation steps were performed in dark moisture chambers at 21°C.
Statistics
Statistical analyses were performed using GraphPad Prism (version 5.0 f; GraphPad Software, San Diego, CA, USA). One-way ANOVA with post hoc analysis using Dunnett's multiple comparison test was used for HPLC and ELISA data, and Tukey's multiple comparison test for cell adhesion data. Two-way ANOVA with Bonferroni's post hoc test was performed to compare samples with and without HCO 3 − /CO 2 . Data are representative of at least three independent experiments, with p < 0.05 considered significant. Details of the tests used in particular analyses are given in the appropriate figure legends.
Results
Effect of ONOOH and ONOOCO 2
-on tropoelastin (TE) structure TE (5 μM) was exposed to increasing concentrations of reagent ONOOH (molar ratios 1 -250 fold over protein, i.e. 5 μM -1.25 mM) for 20 mins at 21°C, before being loaded on to SDS-PAGE gels. After separation, the gels were developed with Coomassie® R-250, or silver staining, and subsequently imaged. Under these conditions, exposure of TE to high molar ratios of ONOOH resulted in a decrease in staining of the parent protein band at~60 kDa, and a dose-dependent detection of bands assigned to dimers and higher oligomers ( Fig. 1A ; Coomassiestained gels not shown). The apparent masses of these species do not correspond to exact multiples of that of the parent protein, consistent with increased interactions with SDS; this is a well-established phenomenon with proteins of high hydrophobicity (e.g. membrane proteins [74] ). Significant dimer formation was detected with equimolar or higher levels of oxidant (i.e. an average of a single modification event per protein molecule). With increasing oxidant doses, formation of trimers, tetramers and smeared bands at even higher masses were detected. With very high oxidant excesses, significant amounts of the protein did not enter the gel from the loading wells, resulting in a decreased extent of total staining, though there was an increase in staining at lower molecular masses (< 60 kDa) indicative of protein fragmentation. Decomposed ONOOH even at the highest concentrations used (250-fold excess; indicated as 250x dec.) did not induce any significant changes compared to the untreated controls (Fig. 1) .
Western blotting of separated protein samples, exposed to oxidant in an identical manner, was carried out using two mAbs that recognize well-defined elastin epitopes. The first of these recognises the C-terminal domain 36 [75] , the second mAb (clone BA-4), recognises a repeat sequence (Val-Gly-Val-Ala-Pro-Gly), which is a chemoattractant for fibroblasts and monocytes. Both mAbs recognised native TE at a molecular mass of~60 kDa (Fig. 1B,C) , but the staining intensity of the TE band decreased with increasing ONOOH concentration, indicating significant perturbation of the protein structure and loss of the specific epitopes recognised by these antibodies. The decomposed oxidant at the highest concentration used, did not show any significant differences compared to the control, untreated protein (Fig. 1B,C) . In contrast to the data obtained with silver staining (Fig. 1A) , no significant staining was detected at higher molecular masses with either antibody (Fig. 1B,C) , suggesting that the dimer and higher oligomers formed in response to oxidant treatment have significantly perturbed structures compared to the monomer.
The effect of ONOOCO 2 -, relative to identical concentrations of ONOOH on TE, was examined by including 25 mM HCO 3 -in the reaction buffers to give physiological levels of CO 2 . As shown in Fig. 2A , the presence of HCO 3 -decreased the extent of loss of parent protein as detected by Coomassie-staining, and also against the loss of epitope recognition by the antibody BA-4 ( Fig. 2B) , consistent with ONOOCO 2 -inducing less marked damage and alterations to the protein. As expected the presence of HCO 3 -had no effect of the behaviour of the decomposed oxidant (dONOOH) (data not shown). Western blotting using a mAb against the nitration product 3-nitroTyr showed a dosedependent increase in staining of the parent protein band with increasing ONOOH levels, with significant staining detected at a 10-fold or higher molar excess of ONOOH over protein (Fig. 2C) . No staining was detected with decomposed ONOOH (data not shown). This detection of 3-nitroTyr on the parent protein was accompanied by increased staining of material at both higher masses (detected as broad smearing), and also on specific fragments at lower mass. In particular three discrete bands with approximate molecular masses of~50,~35 and1 5 kDa were detected (Fig. 2) , consistent with selective cleavage of TE by ONOOH at particular sites in the protein sequence. These fragments were less readily observed with either Coomassie staining or Western blotting experiments using the BA-4 mAb. The presence of HCO 3 -appeared to decrease the extent of 3-nitroTyr detection both on the parent protein band and on the observed fragments. These data indicate significant modification of Tyr residues present on TE, with formation of 3-nitroTyr, but the concentration of these species cannot be determined from these gels.
Quantification of amino acid residues in recombinant human TE on ONOOH exposure
In order to determine the extent of modification of Tyr residues, and 3-nitroTyr formation, as well as potential modification at other residues, amino acid analysis was carried out using HPLC with either acid (data not shown) or enzymatic hydrolysis (Fig. 3A) . This technique allows quantification of all of the common amino acids with the exception of cysteine/cystine and proline residues, with the pairs of glutamine/glutamic acid and asparagine/aspartic acid eluting as single peaks as a result of hydrolysis of the amide to the corresponding carboxylic acids. The resulting data were normalized against isoleucine to compensate for any protein loss during sample preparation and variable efficiency of hydrolysis. For the non-modified samples, comparison of this experimental data with the theoretical amino acid content of TE (Supplementary Table 1 ), gave identical ratios (within experimental error) of each amino acid (relative to isoleucine) to that expected, with the exception of aspartic acid which elutes very close to the void volume, and whose quantification was affected by this. These data confirm the high purity of the protein, and the absence of any Trp and Met residues in the protein. Comparison of the data obtained from the untreated samples compared to those treated with ONOOH, in either the absence or presence of HCO 3 -, indicated that Tyr was the only amino acid whose concentration was significantly affected by ONOOH treatment, with a significant loss of this amino acid detected with a 25-fold or greater molar oxidant excess over protein using the enzymatic method (Fig. 3A) , or with a 50-fold, or greater, molar oxidant excess using the acid hydrolysis technique (data not shown). No significant difference was detected in the extent of Tyr loss between the samples exposed to ONOOH in the absence or presence of HCO 3 -, though there was a trend towards a greater loss in the absence of HCO 3 - (Fig. 3A) .
The extent of 3-nitroTyr formation was examined using the enzymatic hydrolysis method (Fig. 3B) , with a dose-dependent increase in the yield of this protein modification product detected with increasing levels of ONOOH, in the absence of HCO 3 -, up to a 50-fold or greater molar oxidant excess over protein. At higher molar excesses of ONOOH the levels of this product reached a plateau, and then subsequently decreased with very high oxidant concentrations. A significant extent of formation of this material, relative to the control (untreated) or decomposed oxidant-treated samples, was detected with a 5-fold molar excess of oxidant. For experiments carried out in the presence of ONOOH and HCO 3 -, significant levels of 3-nitroTyr were also detected, with this becoming significant with a 10-fold molar excess of oxidant over protein, with a plateau concentration of 3-nitroTyr detected at a 25-fold or higher levels of oxidant. However, the absolute levels of 3-nitroTyr detected in the presence of HCO 3 -were significantly lower than those detected in its absence, consistent with the gel data (Fig. 2C) . These data are consistent with Tyr residues being the major target of ONOOH in TE, and with near 100% loss of parent Tyr detected at very high ONOOH levels.
Identification of protein cross-links in recombinant human TE on ONOOH exposure
The detection of higher mass species of TE after exposure to ONOOH on the gels (Fig. 1A) is consistent with the presence of covalent nonreducible bonds between TE molecules. The significant consumption of Tyr residues and the known formation of cross-linked species from this amino acid (e.g. di-tyrosine, and cross-links involving quinones derived from Tyr [76] ) prompted an examination of the nature of the cross-links formed in ONOOH-treated TE. The presence of cross-links was investigated by making use of the addition mass differences present in cross-linked peptides containing two carboxyl termini after protein digestion by trypsin in Recombinant TE (5 μM) in 0.1 M phosphate buffer pH 7.4 was exposed to ONOOH at the molar ratios indicated, in the absence (-) or presence (+) of 25 mM HCO 3 -, for 20 min at 22°C followed by separation on 3-8% Tris-acetate gels under reducing conditions. (A) Protein staining using Coomassie Blue. (B, C) Western blotting on nitrocellulose membranes probed using (B) the anti-TE mAb (clone BA-4), or (C) a anti-3-nitroTyr pAb (#10189540). The position of the molecular mass markers (HMW) are shown for reference. Lanes marked "SDS 100x" are TE samples (as above) pretreated with SDS to unfold the protein, before treatment with a 100-fold molar excess of ONOOH. These lanes therefore represent maximal epitope exposure / staining. Representative gel images from multiple independent experiments. molar excess of ONOOH ( Supplementary Fig. 1 ). The MS/MS spectrum of this species (Fig. 4A ) revealed several fragment ions that retain the cross-link site (y 5 -y 10 ions for the β peptide and y 14 -y 15 , b 5 -b 9 for the α peptide), providing strong evidence for the presence of the Y-Y crosslink. This cross-linked peptide comprises sequential sections of the protein sequence (i.e. the amino acid sequence is LPGGYGLPYTTGKL-PYGYGPGGVAGAAGK, with tryptic cleavage occurring after the K residue in the middle of this sequence. It is unclear (due to the absence of a high resolution structure of the protein) whether this is an intramolecular cross-link arising from a close spatial alignment of the two Tyr residues as a result of a loop in the secondary structure, or whether this is an inter-molecular cross-link. Strong evidence was also obtained for a cross-link between Tyr (Y) residues in two peptides with sequence LPYGYGPGGVAGAAGK (i.e. LPYGYGPGGVAGAAGK LPYGYGPGGVAGAAGK, cross-link #2, Fig. 4B,C) . This Y-Y link appears in two sets of cross-linked peptides containing different modifications on the second (non cross-linked) Tyr residue (i.e. at Y in LPYGYGPGGVAGAAGK). In the first species (Fig. 4B) this Tyr is subjected to oxidation (+15.99, i.e. hydroxylation to give DOPA) and nitration (+44.985, 3-nitroTyr), respectively, in the Data were analyzed by 1-way ANOVA (with *, ** and *** indicating a significant difference compared to the controls at the p < 0.05, 0.01 and 0.001 levels respectively), or 2-way ANOVA (to examine the effect of the presence of NaHCO 3 ; with # indicating a significant difference compared to the absence of NaHCO 3 ). two peptide chains (experimental mass 2926.429 Da compared to theoretical value of 2926.43 Da; 2.77 ppm mass difference). In the second species (Fig. 4C ) the corresponding Tyr residue is nitrated in both peptide chains (experimental mass 2955.408 Da compared to theoretical value of 2955.414 Da; 2.03 ppm mass difference). The intensity of both cross-linked peptides was highest in the sample treated with 25-fold molar excess (Supplementary Fig. 1 ). As both these species contain two copies of the same peptide, it is concluded that these must correspond to an inter-molecular cross-link.
A cross-link was also detected between AGYPTGTGVGPQAAAAAAAK LPGGYGLPYTTGKLPYGYGPGGVAGAAGK (cross-link #3, Fig. 4D ). This species (experimental mass 4481.285 Da compared to theoretical mass 4481.272 Da; 6.3 ppm mass difference) was detected with oxidation (+ 15.99, hydroxylation) at the second Tyr in the second peptide (i.e. at Y in LPGGYGLPYTTGKLPYGYGPGGVAGAAGK), a residue involved in cross-link #2. The MS/MS spectrum of this cross-linked peptide shows that the b 5 -b 8 fragment ions for the α peptide (longer peptide, in blue) retain the cross-links, as well as the b 6 -b 7 ions for the β peptide (shorter peptide, in red). Whether this is an inter-or intra-molecular cross-link species remains to be established, due to the absence of a high-resolution structure of this protein. The abundance of this cross-linked peptide is highest in 25-fold molar excess of ONOOH, followed by 1-and 2.5-fold molar excess ( Supplementary Fig. 1 ).
In vivo detection of 3-nitroTyr and modified elastin in human arterial and aortic lesions
As elastin is highly abundant in major arteries and evidence has been presented for changes in this protein during atherogenesis [31, 32] , and to be associated with areas of lipid deposition [33, 34, 55] , we examined in human atherosclerotic lesions, the potential colocalization of both elastin and 3-nitroTyr epitopes and lipid pools (as evidenced by Oil Red staining). Fig. 5(A-C) shows an arteria femuralis with a heavily thickened intima. Pronounced staining for elastin is present in the media, in particular in elastic membranes, while faint staining for elastin is present deep in the intima close to the borderline of the media (Fig. 5A) . Faint staining for 3-nitroTyr is present in the area of the endothelial layer (Fig. 5B) . While no staining for 3-nitroTyr was found in the media, abundant staining for 3-nitroTyr occurs in the deeper intima region as well as in the middle portion of the intima (Fig. 5B) . The latter area is heavily invaded with foam cells detected by Oil red staining (Fig. 5C ). These cells (monocytes/macrophages) primarily account for the pronounced 3-nitroTyr staining (Fig. 5B) . To confirm the specificity of the anti 3-nitroTyr for nitrated epitopes in human arterial and aortic material (Fig. 5B, D) , the pAb was preabsorbed with an excess of either nitrated TE or native (unmodified) TE before use with serial sections of human aorta abdominalis. While nitrated TE diminished immunoreactivity to background staining levels (Fig. 5E) , native TE, used as a competitor, did not affect staining for 3-nitroTyr epitopes (Fig. 5F  vs. Fig. 5D ).
Sections were also examined by double immunofluoresecence for the presence of elastin using the mAb 10B8, which recognises human elastin, and 3-nitroTyr epitopes using a rabbit anti-3-nitroTyr pAb (Fig. 6) . The anti-elastin antibody, as expected, provided evidence for the presence of high levels of elastin underneath the endothelial layer (Fig. 6A) . The staining for elastin shows the characteristic layered structure of elastic laminae. Limited fluorescence was detected deeper in the tissue sections. Corresponding experiments examining the presence of 3-nitroTyr epitopes also provided evidence, in line with previous observations [46, [48] [49] [50] , for significant levels of this material underneath the endothelial layer (Fig. 6B) . Merging of these images (Fig. 6C) showed pronounced staining for elastin and 3-nitroTyr epitopes in close proximity with partial colocalization within tissue sections from the lesions. This data are consistent with damage to both elastin, and other matrix components, with damage particularly localized to the lamina closest to the luminal surface. Control experiments using non-immune mouse or rabbit IgG showed no artifactual staining.
Discussion
The studies reported here examined the hypothesis that TE, the precursor of the major ECM protein elastin, would be a major target for modification by the major inflammatory oxidants ONOOH and ONOOCO 2 -due to its unique amino acid composition, that this would result in the formation of high yields of 3-nitroTyr, and that these modifications would result in altered structural and functional properties of the protein, with the latter tested both in vitro and in vivo. These studies complement previous studies on this protein (which used very high excesses of oxidant [59, 60] ), other isolated ECM proteins (perlecan, laminin, fibronectin [48] [49] [50] 78] ), as well as basement membrane extracts, cell culture-derived materials and tissue extracts which contain mixtures of these species [63, 78] . It has been shown that exposure of TE to ONOOH has a dramatic effect on the composition and structure of the protein, with significant levels of 3-nitroTyr detected with very low levels of ONOOH, and formation of modified forms of the protein (both aggregates and fragments) as detected by silver staining, Western blotting with two different antibodies and also by MS analysis. These changes are detected with molar excesses of ONOOH in the range 1-5 fold, or greater, thus even single hits (i.e. equimolar amounts of ONOOH to target) appear to be capable of inducing significant changes to the structure of this protein. Of particular interest was the observed loss of recognition of the C-terminal domain of TE, by the corresponding antibody, as this region has been linked with a number of functional properties including elastin-fibre assembly and cell binding [4, 21, 22, 75, 79] . However, sequence data for TE indicates that there are no Tyr residues in the protein near the C-terminus (the closest is approximately 50 residues away; Fig. 8 ), but this does not preclude a close spatial alignment of a critical Tyr residue that is far removed from the C-terminus. Resolution of this issue awaits a high-resolution structure of the protein. It should however also be noted that this C-terminal region contains the sole disulfide (cystine) cross-link in the protein and it is known that ONOOH can oxidize such residues ( [62, 80] ; L. Carroll, M. Ignasiak, unpublished data) and this may give rise to the decreased antibody recognition. Protein bound 3-nitroTyr was detected on both the main parent TE band, and also on fragments with distinct molecular mass. The masses of these fragments are similar to those that arise from thrombin and kallikrein cleavage [81] . Kallikrein and thrombin are serum proteases capable of degrading TE with thrombin cleaving at Arg 515 (and to lesser extent at Lys 152) whereas kallikrein recognises Arg 515 (at the end of domain 25) and Arg 564 (within domain 26) [82, 83] . Such enzymatic cleavage gives three major fragments with masses of 45, 31 and 13 kDa. The region of TE between these cleavage sites contains domain 26, which is known to play a major role in coacervation and correct elastic fibre assembly [83] .
The sensitivity of TE to modification by ONOOH is likely to arise, at least in part, from the unusual parent amino acid composition of this protein, which contains no free Cys residues (though it does contain 2 Cys residues that form an intrachain disulphide bond [84] ), Met, Trp, or His residues. Each of these species, together with Tyr, is a known, or potential, target for the inflammatory oxidants ONOOH and ONOOCO 2 - [62, 85] . The absence of these other reactive residues was predicted to result in Tyr residues being quantitatively the most important major target, though limited reaction at the single disulfide (cystine) may also occur [62, 85] . This has not been quantified, but is likely to account for only a modest amount of the added ONOOH (see also below). The amino acid analysis confirms the marked selectivity for Tyr residue modification, with this being the only amino acid, of those analyzed (i.e. excluding cystine) depleted significantly on ONOOH exposure. The loss of Tyr was mirrored by the formation of 3-nitroTyr residues (detected both by UPLC analysis and by MS to a more limited extent), with both Tyr loss and 3-nitroTyr formation occurring to a lower extent in the presence of HCO 3 -. This is likely to be due to the formation of ONOOCO 2 -via reaction of ONOO -with CO 2 , with this species being less efficient at both oxidising Tyr, and generating 3-nitroTyr. This decreased reactivity of ONOOCO 2 -is consistent with previous data with other matrix proteins [48] [49] [50] , but may be specific to such materials as previous studies have reported increased levels of nitration in the presence of CO 2 [86, 87] . In both the absence or presence of HCO 3 -, a dosedependent increase in 3-nitroTyr was observed, followed by a plateau, and a decrease in the case of ONOOH alone. These data suggest that 3-nitroTyr is modified or lost via additional reactions, with this potentially involving formation of 3,5-dinitroTyr, an established secondary oxidation product of 3-nitroTyr. Reaction at Phe residues, of which there are 16 in TE, is also a possibility at these high oxidant levels, with this giving 4-nitrophenylalanine as well as p-, m-and o-tyrosine [88, 89] , but this does not appear to be a major fate of the added ONOOH, as no significant loss of parent Phe was detected. The possible formation and quantification of 3,5-dinitroTyr has not been examined, as this is only likely to be of relevance with high oxidant excesses, that are of limited, or no, biological relevance. Further information as to the significance of 3-nitroTyr formation in the modification of TE has been obtained by determining the percentage conversion of Tyr to 3-nitroTyr (Fig. 7A) , and the percentage conversion of ONOOH to 3-nitroTyr (Fig. 7B) . With regard to the former it can be seen that up to 15% of the Tyr residues present in TE are converted to 3-nitroTyr at a 50-fold molar ratio of ONOOH to TE. As there are 15 Tyr residues per mole of TE this equates, on average, to a total of 2 modified Tyr residues per protein molecule with this damage likely to be spread over multiple Tyr residues, when exposed to With regard to the extent of conversion of ONOOH to 3-nitroTyr, the maximum extent of conversion of oxidant to this product peaks at approximately 8% for the system in the absence of HCO 3 -, and 5% in its presence (Fig. 7B) . As with Fig. 7A , this plot shows a marked inverted "U" shape consistent with the occurrence of further/secondary reactions at high oxidant concentrations. Whilst these percentage conversion values may initially appear low, it should be noted that this is a very high value when compared to data for reaction of this oxidant with other biological targets [48] [49] [50] 61, 62, 78] . A low percentage conversion is typically detected for this oxidant as a result of the occurrence of the rapid spontaneous conversion of ONOOH to nitrite (NO 2 -) and nitrate (NO 3   - ) and, where Tyr residues are the target, the requirement for two successive reactions to generate 3-nitroTyr, via initial formation of the Tyr phenoxyl radical, and then subsequent reaction of this species with NO 2 .
. This results in a low overall product yield. Clearly the extent of these (and other) competing pathways for ONOOH are highly dependent on the reaction conditions and reactant concentrations, but the high detected levels of conversion with the relatively modest concentrations of TE used in these experiments (10 μM) suggest that 3-nitroTyr formation from Tyr is a quantitatively important reaction. Furthermore, given the very high level of 30-55% of mature elastin in the aorta, it may also be a major process in vivo; this is currently being examined.
The detection of aggregates of TE with low levels of ONOOH exposure by SDS-PAGE and also MS is consistent with oxidation of Tyr residues to Tyr phenoxyl radicals. Subsequent reaction of these radicals with NO 2 . are likely to be the major route to 3-nitroTyr, however dimerization of two phenoxyl radicals to give di-tyrosine also appears to be a major fate of these species, with this pathway proposed to be the major route to (irreversible) cross-link formation. The MS data has provided evidence consistent with both inter-and intra-molecular cross-links. Although two of the detected cross-links can be attributed to either inter-or intra-molecular linkages, the detection of a cross-link between the Tyr residues of two identical peptides of sequence LPYGYGPGGVAGAAGK provides convincing evidence of covalent intermolecular protein cross-links. Of particular interest is the observation that the two Tyr residues involved in cross-link #1 (i.e. the two Tyr residues highlighted in bold in the sequence LPGGYGLPYTTGKLPYGYGPGGVAGAAGK) are also involved in both the other cross-links that have been detected. Furthermore, oxidation and nitration (to give 3-nitroTyr) were also detected within this sequence (at Y in the above sequence).
All of these cross-links occur within one part of the protein sequence ( Fig. 8 ; Tyr residues involved in cross-links are Y217, Y221, Y228 and Y244, with oxidation / nitration also detected at Y221 and Y230; numbering using the complete protein sequence from UniProtKB entry P15502) suggesting that this section of the molecule must both react readily and rapidly with the oxidant, and be a highly accessible (or flexible) region on the protein surface, in order to allow rapid crosslinking and oxidation / nitration to occur. This suggestion is supported by the detection of cross-links with very low levels of ONOOH (equimolar or greater concentrations). The Tyr residues involved in these cross-linked peptides and the oxidations / nitrations are indicated in Fig. 8 .
The ability of TE to self-assemble (coacervate), is a critical factor in its biological function, and it is likely that exposure to even low levels (equimolar concentrations) of oxidant can modulate this process. This may arise from rapid and efficient modification at a limited number of Tyr residues within the protein with this resulting in efficient interprotein cross-links. The formation of intra-protein cross-links may also alter coacervation via modification of the 3-dimensional structure of the monomer protein. Experiments performed by Akhtar et al. [59, 60] indicate that ONOOH affects elastic fibre assembly and cell binding, with abnormal coacervation behaviour of oxidised TE detected at low temperatures when compared to native TE. Furthermore, human retinal pigment endothelial cells incubated with oxidised TE were unable to incorporate the oxidised material into existing fibres [59] . Disorganized elastic fibre composition and reduced artery wall integrity (as evidenced by a greater extent of fragmented internal elastic laminae) is a known feature in cardiovascular disease in both humans [37] and many mouse strains [90] (though not apparently elastin heterozygous Fig. 7 . Quantitative assessment of the absolute levels of (Panel A) conversion of Tyr residues in tropoelastin (TE) to 3-nitroTyr, and (Panel B) ONOOH conversion to 3-nitroTyr with increasing molar ratios of ONOOH to TE. Data are recalculated from the experimental data presented in Fig. 3 using the absolute levels of oxidant and parent and modified residues (corrected for recovery), the abundance of Tyr residues in the parent TE (15) , and the relevant injection volumes. In both plots, the black bars indicate data obtained in the absence of HCO 3 -, and grey bars data obtained in the presence of 25 mM HCO 3 -. Values are expressed as means ± SEM from n ≥ 3 independent experiments. Data were analyzed by 1-way ANOVA (with * indicating a significant difference compared to controls at the p < 0.05 level and *** indicating p < 0.001), or 2-way ANOVA (to examine the effect of the presence of NaHCO 3 ; with # indicating a significant difference compared to the absence of NaHCO 3 ).
knockout mice [91] ), and together these data suggest that this might be due to either modification by ONOOH of newly-synthesised TE, which then does not incorporate (or incorporates incorrectly) into existing fibres, or ONOOH-induced changes to mature elastin. A previous study has also reported elevated levels of 4-hydroxynonenal-modified elastin in human atherosclerotic lesions, consistent with elastin being modified by material derived from oxidised lipids [19] . The data reported here for the human atherosclerotic lesions is consistent with the presence of significant levels of 3-nitroTyr, with the staining for this epitope appearing to occur primarily in the vicinity of lipid-laden macrophage cells. This is consistent with previous data [48] , and suggests that activated macrophages are a major (though not necessarily the only) source of ONOOH in such lesions, and implicates the inducible nitric oxide synthase enzyme of these cells as a major driver of oxidant damage. The colocalization of the 3-nitroTyr epitopes with (at least in part) elastin and elastic lamina structures is consistent with the previous reports (see above) of elastin modification in human atherosclerotic lesions, and a potential role for such elastin (and other ECM) modifications in the accumulation of lipid deposits within the artery wall [34, 55] . One limitation of the current data is that the time course (i.e. sequence) of these events cannot be established, due to the difficulty in obtaining material from the earliest stages of human lesion development. Thus, it remains to be established whether lipid accumulation in macrophages is a driver of subsequent matrix modifications, or whether activation of macrophages induces modification to elastin (and other matrix materials) with these modified matrix molecules enhancing subsequent ingress, retention and modification of lipidcontaining particles (e.g. low-density lipoproteins) in the artery wall, with subsequent uptake by macrophages, via scavenger receptors to give foam cells.
In conclusion, these data indicate that isolated TE is a major and highly susceptible target for the inflammatory oxidant ONOOH, with this resulting in marked and selective conversion of the Tyr residues in this protein to 3-nitroTyr and dityrosine cross-links. This selectivity appears to arise from the absence of other ONOOH-reactive residues, and gives very high extents of conversion of Tyr to 3-nitroTyr (with up to 2 Tyr residues modified per mole of protein), and ONOOH to this product (up to 8% conversion), as well as significant cross-link formation. These levels of conversion of Tyr to 3-nitroTyr are much higher than detected with other matrix proteins studied to date (e.g. perlecan, fibronectin and laminin [48] [49] [50] , though whether the extent of modification correlates strongly with functional effects and biological consequences has yet to be determined. Further extrapolation of this in vitro data to in vivo situations is unlikely to be sensible. Exposure of TE to ONOOH also generates inter-(and possibly intra-) molecular crosslinks, as well as the formation of specific fragments that contain 3-nitroTyr residues; these changes occur with very low levels of oxidant (1-5 fold molar excesses), consistent with a possible pathological relevance. This conclusion is supported by the detection of 3-nitroTyr in human atherosclerotic lesions and its co-localization with both lipid pools and elastin. Fig. 8 . Primary sequence of isoform 3 ("canonical sequence") of human tropoelastin (TE) indicating sites of cross-links and modifications detected by MS analysis. Sequence data from UniProtKB, entry P15502, minus the N-terminal signal peptide (residues . The Tyr (Y) residues identified in inter-or intramolecular cross-links are indicated in red text with yellow background, with the corresponding peptide sequences involved in these cross-links indicated by underscoring. The Tyr residue identified as either hydroxylated (probably DOPA) or nitrated (3-nitroTyr) species by MS analysis is indicated in blue text. Tyr residue (Y) 221, which is involved in these cross-links was also detected as an oxidised (+15.99; probably DOPA) species. The two Cys residues involved in the formation of the cystine disulfide bridge at the C-terminus are indicated in green text.
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